𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Analysis of prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization

✍ Scribed by Keiji Yamamoto; Manabu Masuzawa; Michio Kato; Takumasa Okuyama; Kazuya Tamura

Publisher
Springer
Year
1992
Tongue
English
Weight
497 KB
Volume
31
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Postresection recurrence of hepatocellul
Postresection recurrence of hepatocellular carcinoma treated by arterial embolization: Analysis of prognostic factors
✍ Kenichi Takayasu; Fumihiko Wakao; Noriyuki Moriyama; Yukio Muramatsu; Susumu Yam πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 628 KB

Of 270 consecutive patients with hepatocellular carcinoma who underwent surgery, 60 who had recurrence and were subsequently treated with transcatheter arterial embolization were analyzed. The longest interval between surgery and recurrence in the 60 patients who underwent transcatheter arterial emb

A pilot study of transcatheter arterial
A pilot study of transcatheter arterial interferon embolization for patients with hepatocellular carcinoma
✍ Man-Fung Yuen; Clara Gaik-Cheng Ooi; Chee-Kin Hui; Wai-Man Wong; Benjamin Chun-Y πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 129 KB

## Abstract ## BACKGROUND Systemic, high–dose interferon‐α treatment given three times per week subcutaneously induces tumor regression in approximately 30% of patients with inoperable hepatocellular carcinoma (HCC). The objective of the current study was to determine the efficacy and safety of tr

Interleukin-6 in transcatheter arterial
Interleukin-6 in transcatheter arterial embolization for patients with hepatocellular carcinoma. Effects of serine protease inhibitor
✍ Yukihiko Matsuda; Sumio Kawata; Toshihiko Nagase; Yuichi Maeda; Eiji Yamasaki; S πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 446 KB πŸ‘ 2 views

Background. Modulation of serum levels of circulating cytokines and inflammatory responses with a serine protease inhibitor was studied in 34 patients with hepatocellular carcinoma (HCC) after transcatheter arterial embolization (TAE). Methods. The 34 patients were randomly divided into two groups: